Search Results - "George, Barry S"

Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia by Ansel, Gary M., Sample, Nancy S., Botti III, Jr, Charles F., Tracy, Amy J., Silver, Mitchell J., Marshall, Brian J., George, Barry S.

“…Options for lower limb percutaneous revascularization are limited especially for complex vessel obstruction. Cutting balloon angioplasty (CBA) has been…”
Get full text

Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction by GRINES, C. L, TOPOL, E. J, O'NEILL, W. W, GEORGE, B. S, KEREIAKES, D, PHILLIPS, H. R, LEIMBERGER, J. D, WOODLIEF, L. H, CALIFF, R. M

“…Smoking is known to be a strong risk factor for premature atherosclerosis, myocardial infarction, and sudden cardiac death. Unexpectedly, in the reperfusion…”
Get full text

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction by Topol, E J, Califf, R M, George, B S, Kereiakes, D J, Abbottsmith, C W, Candela, R J, Lee, K L, Pitt, B, Stack, R S, O'Neill, W W

“…We compared the efficacy of immediate coronary angioplasty after acute myocardial infarction with that of elective angioplasty at 7 to 10 days in patients…”
Get more information

CASE 11—2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? by Essandoh, Michael K., Dalia, Adam A., George, Barry S., Flores, Antolin S., Otey, Andrew J., Kirtane, Ajay J., Broderick, Thomas M., Rao, Sunil V.

Get full text

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction by BRENER, S. J, BARR, L. A, MOSES, J. W, MOLITERNO, D. J, EFFRON, M. B, TOPOL, E. J, BURCHENAL, J. E. B, KATZ, S, GEORGE, B. S, JONES, A. A, COHEN, E. D, GAINEY, P. C, WHITE, H. J, CHEEK, H. B

“…Background —The benefit of catheter-based reperfusion for acute myocardial infarction (MI) is limited by a 5% to 15% incidence of in-hospital major ischemic…”
Get full text

Abciximab readministration: Results of the reopro readministration registry by TCHENG, James E, KEREIAKES, Dean J, DAMARAJU, Lakshmi, SCHANTZ, Allen, EFFRON, Mark B, BRADEN, Gregory A, LINCOFF, A. Michael, GEORGE, Barry S, KLEIMAN, Neal S, SANE, David C, CINES, Douglas B, JORDAN, Robert E, MASCELLI, Mary Ann, LANGRALL, Mary Ann

“…Platelet glycoprotein IIb/IIIa blockade with abciximab (ReoPro) improves the clinical outcomes of percutaneous coronary intervention. This registry was…”
Get full text

Case Report: Post transcatheter aortic valve replacement shock: Value of multimodal imaging [version 1; peer review: 1 approved, 1 approved with reservations] by Bhandary, Sujatha P, Otey, Andrew J, Papadimos, Thomas J, Crestanello, Juan A, George, Barry S, Turner, Katja R

“…Complications resulting from the delayed clinical presentation of a left main coronary artery obstruction can be catastrophic. This case report presents a…”
Get full text

Distal embolic protection--don't cause a stroke trying to prevent one by George, Barry S

Get more information

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: Experience with the AngioJet catheter by Silva, Jose A., Ramee, Stephen R., Cohen, David J., Carrozza, Joseph P., Popma, Jeffrey J., Lansky, Alexandra A., Dandreo, Kim, Baim, Donald S., George, Barry S., McCormick, Daniel J., Setum, Cindy M., Kuntz, Richard E.

“…Background Although balloon angioplasty and stenting are effective in the treatment of acute myocardial infarction (MI), reduced coronary flow and distal…”
Get full text

Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction by Topol, Eric J, Ellis, Stephen G, Califf, Robert M, George, Barry S, Stump, David C, Bates, Eric R, Nabel, Elizabeth G, Walton, Joseph A, Candela, Richard J, Lee, Kerry L, Kline, Eva M, Pitt, Bertram

“…Current limitations of recombinant tissue-type plasminogen activator (rt-PA) therapy for acute myocardial infarction include failure to achieve recanalization…”
Get full text

Final results of the ReoPro readministration registry by Dery, Jean-Pierre, Braden, Gregory A, Lincoff, A.Michael, Kereiakes, Dean J, Browne, Kevin, Little, Thomas, George, Barry S, Sane, David C, Cines, Douglas B, Effron, Mark B, Mascelli, Mary Ann, Langrall, Mary Ann, Damaraju, Lakshmi, Barnathan, Elliot S, Tcheng, James E

“…Because of its potential for antigenicity, theoretical concerns related to readministration of abciximab have been raised. We conducted the ReoPro…”
Get full text

Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes by George, Barry S., Roubin, Gary S., Fearnot, Neal E., Pinkerton, Cass A., Raizner, Albert E., King, Spencer B., Holmes, David R., Topol, Eric J., Kereiakes, Dean J., Hartzler, Geoffrey O., Voorhees, William D.

“…Objectives. This study reports on the initial experience with the Gianturco-Roubin flexible coronary stent. The immediate and 6-month efficacy of the device…”
Get full text

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortality by Bates, Eric R, Califf, Robert M, Stack, Richard S, Aronson, Lynne, George, Barry S, Candela, Richard J, Kereiakes, Dean J, Abbottsmith, Charles W, Anderson, Linda, Pitt, Bertram, O'Neill, William W, Topol, Eric J

“…The influence of infarct location on arterial patency, left ventricular function and mortality after 150 mg of intravenous recombinant tissue-type plasminogen…”
Get full text

Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction : results of a randomized trial by OHMAN, E. M, GEORGE, B. S, TAYLOR, G, LEIMBERGER, J. D, OWENS, P. M, LEE, K. L, STACK, R. S, CALIFF, R. M, WHITE, C. J, KERN, M. J, GURBEL, P. A, FREEDMAN, R. J, LUNDERGAN, C, HARTMANN, J. R, TALLEY, J. D, FREY, M. J

Get full text

Cutting balloon angioplasty teaching the old dog new tricks by George, Barry S

Get more information

Clinical results for the training-phase roll-in patients in the intracoil femoralpopliteal stent trial by Ansel, Gary M., Botti Jr, Charles F., George, Barry S., Kazienko, Brian T.

“…The purpose of this study was to report the results of the roll‐in patients for the multicenter IntraCoil trial in the femoropopliteal arteries at 9‐month…”
Get full text

Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: Development of a predictive model by O'Connor, Christopher M., Hathaway, William R., Bates, Eric R., Leimberger, Jeffrey D., Sigmon, Kristina N., Kereiakes, Dean J., George, Barry S., Samaha, Joseph K., Abbottsmith, Charles W., Candela, Richard J., Topol, Eric J., Califf, Robert M.

“…Ischemic heart disease is the most common cause of congestive heart failure, which often begins after acute myocardial infarction. To better delineate the…”
Get full text

Comparison of resource utilization and discharge status between aortic stent grafting and open surgical aneurysm repair in a large community hospital by Ansel, Gary M., Snow, Richard J., Wiseman, Lori, George, Barry S., Botti, Charles F., Silver, Mitchell J., Watson, Daniel R., Blossom, Geoffrey B.

Get full text

Why endovascular therapy should be utilized before surgical bypass for femoropopliteal occlusive disease by Ansel, G M, Botti, C F, Silver Barry S George, M J, George, B S

Get more information

Use of glycoprotein IIb/IIIa platelet inhibitors in peripheral vascular interventions by Ansel, Gary M, George, Barry S, Botti, Charles F, Silver, Mitchell J

“…With the expanding use of endovascular techniques for the treatment of peripheral vascular disease, consideration of glycoprotein IIb/IIIa receptor inhibitors…”
Get more information